PMID- 11578443
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20191120
IS  - 1525-1438 (Electronic)
IS  - 1048-891X (Linking)
VI  - 4
IP  - 6
DP  - 1994 Nov
TI  - DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer.
PG  - 408-413
AB  - Nuclear DNA content and p53 immunoreactivity were determined in 53 cases of 
      primary fallopian tube cancer (PFTC). All tumors showed a distinctly aneuploid 
      DNA distribution pattern, whereas p53 immunoreactivity was observed in 51% of the 
      cases. If the patients were divided into two groups according to survival time, 
      p53 immunoreactivity was present in 40% of the tumors from patients surviving for 
      more than 8 years and in 65% of tumors from patients who died within 2 years. 
      This difference was not statistically significant (P = 0.438). Patient survival 
      was significantly correlated to the clinical stage (FIGO) (P = 0.0009).
FAU - Hellstrom, A-C
AU  - Hellstrom AC
AD  - Department of Gynaecology and Oncology, Radiumhemmet, and Department of Tumor 
      Pathology, Karolinska Hospital and Institute, Stockholm, Sweden.
FAU - Hue, J
AU  - Hue J
FAU - Silfversward, C
AU  - Silfversward C
FAU - Auer, G
AU  - Auer G
LA  - eng
PT  - Journal Article
PL  - England
TA  - Int J Gynecol Cancer
JT  - International journal of gynecological cancer : official journal of the 
      International Gynecological Cancer Society
JID - 9111626
EDAT- 1994/11/01 00:00
MHDA- 2001/10/02 10:00
CRDT- 1994/11/01 00:00
PHST- 1994/11/01 00:00 [pubmed]
PHST- 2001/10/02 10:00 [medline]
PHST- 1994/11/01 00:00 [entrez]
AID - 04060408 [pii]
AID - 10.1046/j.1525-1438.1994.04060408.x [doi]
PST - ppublish
SO  - Int J Gynecol Cancer. 1994 Nov;4(6):408-413. doi: 
      10.1046/j.1525-1438.1994.04060408.x.